Best sellers

DNSP-11 is a short amidated peptide derived from the proGDNF domain that has been investigated in preclinical research models for its neurotrophic-like activity within dopaminergic systems. Experimental studies conducted in vitro and in vivo suggest that DNSP-11 may support dopaminergic neuron resilience, neuroadaptive responses, and neuronal survival mechanisms under conditions of neurodegenerative stress. DNSP-11 has been explored in research contexts related to: Dopaminergic neuron degeneration models Nigrostriatal system dysfunction Neuroprotective and neurorestorative pathways Modulation of dopamine and dopamine metabolite levels Motor asymmetry and behavioral outcome models Neuronal survival and anti-apoptotic signaling Neurite outgrowth and neuronal differentiation Toxin-induced neurodegeneration models FRESHLY PREPARED SOLUTION 

LL-37 is the only known human member of the cathelicidin family, a broad class of proteins commonly referred to as antimicrobial peptides (AMPs). These peptides are primarily expressed in macrophages and polymorphonuclear leukocytes, where they contribute to innate immune defense against microbial threats. Beyond their antimicrobial role, experimental research has demonstrated that LL-37 is involved in a wide range of biological processes related to immune regulation, inflammation, tissue repair, and cellular signaling. For this reason, LL-37 has been extensively studied in research models relevant to cancer biology, autoimmune mechanisms, inflammatory conditions, and wound-related processes. According to experimental research, LL-37 has been investigated in relation to: Inflammatory processes associated with rheumatoid arthritis Immune dysregulation studied in lupus models Chronic and acute inflammatory conditions Vascular inflammation relevant to atherosclerosis research Skin inflammation examined in psoriasis models Intestinal inflammation studied in colitis research Gastrointestinal inflammatory signaling in Crohn’s disease models Tissue injury and repair processes associated with ulcers Impaired wound-healing environments such as diabetic foot models Cellular and immune mechanisms explored in cancer research Broad antimicrobial activity within innate immune defense systems

Organic Germanium GE-132 (carboxyethylgermanium sesquioxide) is a water-soluble organogermanium compound investigated for its effects on immune signaling, chemokine regulation, and oxidative stress pathways. Research consistently highlights modulation of the CCL2–CCR2 chemokine axis, which influences monocyte recruitment and macrophage trafficking, as well as induction of interferon-associated pathways with activation of NK cells and macrophages in experimental models. GE-132 has also been shown to suppress NF-κB and MAPK signaling and reduce inflammatory mediators under controlled conditions. Another key feature is redox modulation. Several studies report protection against hydrogen peroxide–induced oxidative stress, increased intracellular glutathione, reduced LDL oxidation, elevated α-tocopherol levels, and improved antioxidant enzyme activity. In vitro data also indicate increased cellular ATP levels and potential support of mitochondrial bioenergetics. Preclinical oncology research describes effects on tumor microenvironment regulation, macrophage M1 gene polarization, inhibition of the CCL2 pathway, and reduction of tumor progression. Additional experimental contexts include vascular inflammation, myocardial remodeling, neuroinflammatory paradigms, hepatic oxidative injury, antiviral immune signaling, and wound healing biology.

Humanin is a 24–amino acid mitochondrial-derived peptide in which each residue contributes to its biological activity. A key residue is serine at position 14, which is associated with neuroprotective properties. Substitution of this amino acid with glycine results in a more potent variant known as Humanin-G (HNG). Experimental research indicates that HNG exhibits substantially enhanced biological activity compared to native Humanin and is particularly effective in preserving mitochondrial function and cellular integrity under stress conditions. In preclinical and laboratory research settings, Humanin-G has been shown to support cellular survival by limiting mitochondrial dysfunction and reducing pathways associated with programmed cell death. These properties have generated scientific interest in its role within research models of ischemic injury, neurodegenerative processes such as Alzheimer’s disease, and other conditions linked to cellular stress. Based on experimental observations, Humanin-G has been associated with:  Protection against mitochondrial dysfunction in stressed cells Reduction of apoptosis-related cellular pathways Support of cellular longevity mechanisms in research models Modulation of insulin sensitivity in experimental systems Neuroprotective effects observed in models of ischemia and neurodegeneration

BPC-157 is a 15-amino-acid synthetic peptide used in preclinical research models to investigate cellular repair mechanisms, extracellular matrix dynamics, vascular signaling, and tissue stress responses. In in vitro systems and animal studies, BPC-157 has been explored for its involvement in pathways related to fibroblast activity, angiogenesis, nitric oxide-associated signaling, coagulation-related processes, immune modulation, and gene expression regulation under experimental conditions. FRESHLY PREPARED SOLUTION 

FOXO4-DRI is a research peptide investigated for its ability to selectively interact with cellular pathways associated with senescence. Preclinical studies suggest that modulation of senescent cell populations may support improvements in biological function and tissue-level homeostasis in experimental models of aging.  According to experimental and preclinical research observations, FOXO4-DRI has been associated with the following effects: Selective induction of apoptosis in senescent cells in laboratory models Improvement of physical performance parameters in aging animal studies Support of tissue and organ function markers in preclinical research Contribution to the restoration of tissue homeostasis under experimental conditions      

Our Commitment to Analytical Transparency Whenever available, our third-party Certificates of Analysis (COAs) include: - HPLC purity testing - Mass Spectrometry (MS) identity confirmation - Net Peptide Content (NPC) analysis We believe that Net Peptide Content analysis is particularly important for evaluating the actual amount of peptide present, taking into account residual moisture, counterions, and other non-peptide components.Research indicates that P21 is associated with increased levels of brain-derived neurotrophic factor (BDNF), a key molecule involved in neuronal development and synaptic plasticity. BDNF is linked to enhanced neurogenesis and has been shown in experimental models to modulate biological pathways related to amyloid plaque and tau protein formation, both of which are characteristic features of Alzheimer’s disease pathology. In addition, multiple studies suggest that P21 supports learning processes and cognitive performance by promoting neuroplastic mechanisms and maintaining synaptic function in the central nervous system. FRESHLY PREPARED SOLUTION

Sermorelin is a synthetic peptide derived from Growth Hormone-Releasing Hormone (GHRH) that stimulates the pituitary gland to increase endogenous growth hormone secretion. By activating GHRH receptors, Sermorelin promotes physiological GH release and enhances downstream IGF-1 production, supporting anabolic and regenerative signaling. Research suggests it may be relevant in studies involving body composition improvement, bone density support, metabolic regulation, and tissue repair. Additional research interest includes potential cardiovascular recovery effects through reduced scar remodeling, neuroprotective support via IGF-1-mediated neuronal resilience, and systemic benefits in chronic inflammation-related conditions. Due to its feedback-regulated mechanism and sustained receptor responsiveness, Sermorelin remains an important peptide in research related to endocrine aging, regeneration, and long-term metabolic health.

B7-33 has been investigated in preclinical research models related to: Fibrotic tissue remodeling models Vascular protection and endothelial signaling models Cardiac injury and post-ischemic remodeling models Pulmonary inflammation and fibrosis-related models 

Cardiogen is a short synthetic peptide used in preclinical research models to study fibroblast-associated signaling and tissue remodeling mechanisms. In in vitro systems and animal studies, it has been investigated for its role in regulating cellular processes involved in extracellular matrix organization and scar-related responses under experimental conditions.

PE-22-28 is a synthetic derivative of the naturally occurring peptide spadin that targets the TREK-1 channel. Since TREK-1 is found in brain regions that govern mood, memory, and learning, PE-22-28 was designed with the goal of being a potential treatment candidate for depression and a powerful stimulator of neurogenesis and synaptogenesis in the hippocampus. PE-22-28 is currently being researched for several applications, including: Antidepressant activity Enhancement of memory and learning Support for stroke recovery Potential roles in addressing neurodegenerative diseases such as Alzheimer’s Promotion of neurogenesis

Taltirelin is a synthetic TRH analogue studied primarily for its effects in spinocerebellar degeneration and related motor coordination disorders. Acting as a biased superagonist at TRH-R1, it influences central neurotransmission and has been investigated for neuroprotective, anti-ataxic, and pro-cognitive effects. Research suggests taltirelin may modulate multiple neurotransmitter systems, including acetylcholine, dopamine, serotonin, and noradrenaline, contributing to interest in its potential relevance for memory impairment, depressive-like conditions, arousal regulation, and fatigue-related disorders. Additional studies have explored its antinociceptive properties and possible effects on neurite outgrowth and spinal cord-related neural recovery, making it a notable peptide in experimental research involving neurodegeneration, cognition, and neurological resilience.

Vialox is a synthetic pentapeptide investigated in cosmetic research for its interaction with peripheral nicotinic acetylcholine receptors involved in superficial neuromuscular signaling. Facial expression–related micro-contractions generate repetitive mechanical stress on the overlying dermal matrix, contributing over time to the formation of dynamic wrinkles. By modulating acetylcholine receptor–mediated signaling at the neuromuscular interface, Vialox has been studied for its potential to reduce contraction amplitude in superficial expression muscles. Decreased mechanical strain may support improved skin surface smoothness, reduced fine-line visibility, and more balanced dermal tension distribution. Rather than acting through volumizing or structural filling mechanisms, this peptide is investigated within the biomechanical modulation domain of skin aging research, focusing on expression-related wrinkle dynamics and mechanical stress regulation. FRESHLY PREPARED SOLUTION

Most peptides exert their biological effects by interacting with cell surface or intracellular receptors. However, a limited number of peptides are capable of binding directly to DNA, thereby influencing fundamental biological processes at the level of gene regulation. Pinealon is one of these bioregulatory peptides. It has demonstrated neuroprotective properties and is considered a promising candidate for research focused on the modulation and management of various neurological conditions. Pinealon is known to affect the central nervous system by influencing behavior while also protecting neurons and other cell types from oxidative damage. One of the most notable characteristics of Pinealon is its ability to cross the cellular membrane, nuclear membrane, and the blood–brain barrier. This unique property helps explain its capacity to interact directly with DNA and regulate gene expression. Pinealon has been associated in research with potential applications including: Anti-aging effects Neuronal protection Modulation of depressive pathways Research into neurological disorders such as Alzheimer’s disease and Parkinson’s disease Memory enhancement Regulation of sleep and circadian rhythms FRESHLY PREPARED SOLUTION

PNC-27 is a synthetic research peptide studied for its selective activity against malignant cells. It is designed to bind to HDM-2, a protein that is abnormally expressed on the membranes of many cancer cells and is known to interact with the p53 tumor suppressor pathway. Experimental research indicates that PNC-27 can selectively induce cancer cell death by disrupting the integrity of the cancer cell membrane through a process known as membranolysis, while showing minimal interaction with non-cancerous cells.

Research suggests that Retinalamin is of interest in ophthalmology and retinal-support research due to its potential role in supporting retinal tissue function, microcirculation, and recovery mechanisms under conditions of degeneration or vascular stress. Studies indicate that it may be relevant in a range of retinal and vision-related disorders, including diabetic retinopathy, myopic disease, retinitis pigmentosa, age-related macular degeneration (AMD), chorioretinitis, primary open-angle glaucoma, and other eye diseases associated with impaired retinal performance and progressive vision decline. FRESHLY PREPARED SOLUTION

FGL has been investigated in experimental and preclinical research settings for its role in supporting synapse formation between neurons, a process associated with synaptic plasticity and structural neuronal adaptation. Increased activity-dependent synaptic communication observed in research models suggests that FGL may contribute to information encoding mechanisms underlying learning and memory-related processes. According to experimental studies, FGL has been explored in relation to the following neurobiological contexts: Neuroprotective mechanisms in neuronal stress models Modulation of cognitive performance parameters in experimental systems Neural recovery and adaptation following traumatic brain injury models Protection against experimentally induced neurotoxic stress Memory-related processes in learning paradigms Learning-associated synaptic plasticity mechanisms Neurodegenerative and cognitive decline research models Modulation of neuroinflammatory signaling in central nervous system models Regulation of mood-related behavioral parameters in experimental settings Activity-dependent enhancement of excitatory synaptic transmission      

VIP (Vasoactive Intestinal Peptide) is a 28–amino acid neuropeptide of the secretin–glucagon family, widely expressed in the brain, gastrointestinal tract, pancreas, lungs, heart, thyroid, adrenal glands, and thymus. It acts through the GPCR receptors VPAC1 and VPAC2, activating cAMP-related signaling pathways that regulate vascular tone, immune balance, secretion mechanisms, and neuronal survival. Research suggests VIP has neuroprotective and neurotrophic properties, supporting blood–brain barrier integrity, reducing oxidative stress, and modulating neuroinflammation, with relevance in neurodegenerative models such as Alzheimer’s and Parkinson’s disease. VIP also regulates circadian rhythm via hypothalamic signaling, supports gastrointestinal motility and barrier integrity, and has immunomodulatory effects by reducing pro-inflammatory cytokines and promoting immune tolerance. Additional studies indicate antifibrotic and vasodilatory activity relevant to cardiovascular and pulmonary disease models, as well as potential relevance in transplantation tolerance research and lacrimal secretion regulation in dry eye-related conditions.

Chonluten has been explored in relation to the regulation of pulmonary mucosa, gene networks involved in inflammatory and antioxidant processes, and tissue adaptation mechanisms across a broad range of acute and chronic respiratory and systemic stress conditions, of both infectious and non-infectious origin, including age-associated functional decline. Experimental findings indicate a predominant activity within pulmonary tissue, with secondary involvement observed in the gastrointestinal tract. Specifically, Chonluten has been studied in preclinical research contexts involving: post-infectious pulmonary recovery states chronic cardiopulmonary functional impairment persistent respiratory dysfunction recovery phases following prolonged mechanical ventilation long-term pulmonary adaptation after remission of granulomatous conditions acute respiratory distress and hypoxia-associated states high physiological load and exercise-related respiratory stress maintenance of respiratory function in ageing biological systems inflammation-driven pulmonary mucosal dysregulation inflammatory states and alterations of the gastrointestinal mucosa

GHK is a naturally occurring tripeptide that has been widely investigated in experimental and laboratory research for its involvement in multiple biological processes. Scientific studies suggest that GHK is associated with the following research-observed activities: Support of tissue repair processes: Linked to collagen-related pathways and cellular mechanisms involved in wound repair and tissue maintenance. Modulation of fibrinogen-related pathways: Associated with inflammatory signaling regulation and vascular biology mechanisms in experimental models. Activation of DNA repair–related gene networks: Observed to influence pathways connected to genomic stability and cellular maintenance. Engagement of the ubiquitin/proteasome system: Studied for its role in supporting protein quality control and cellular homeostasis. Influence on insulin and insulin-like signaling pathways: Associated with metabolic regulation mechanisms in gene expression studies. Collectively, these properties make GHK a molecule of interest in research areas such as cardiovascular biology, aging mechanisms, metabolic regulation, and tissue regeneration. 

TP508 is a 23–amino acid investigational regenerative peptide derived from amino acids 508–530 of human prothrombin. It has been studied for its ability to stimulate tissue repair by reversing endothelial dysfunction, promoting angiogenesis and revascularization, attenuating inflammation, and reducing apoptosis. Human studies have reported improved healing of diabetic foot ulcers and distal radius fractures, while animal studies suggest TP508 may stimulate bone regeneration in critical-size defects. Emerging evidence indicates that TP508 may activate tissue-derived stem/progenitor cells, which may contribute to its broad regenerative effects. Additional research has explored TP508 in cardiovascular ischemia models, where it increased perfusion and restored nitric oxide signaling through eNOS activation. TP508 has also been investigated as a potential countermeasure for radiation-induced gastrointestinal injury due to its potential role in supporting intestinal stem cell regeneration.

Vilon is a thymus-derived bioregulatory peptide commonly described as the dipeptide Lys–Glu (KE). It is studied for its potential immune-modulating effects, particularly in the context of thymus-related immune function and T-cell regulation. Research suggests Vilon may support immune cell differentiation, normalize cytokine signaling, and contribute to immune homeostasis. These properties make it relevant in studies involving immunosenescence, age-related immune decline, chronic inflammation, infection susceptibility, and immune dysfunction. By supporting balanced immune regulation rather than excessive stimulation, Vilon has become a peptide of interest in research focused on immune resilience, systemic vitality, and longevity-related immune restoration.

Humanin is a 24–amino acid mitochondrial-derived peptide in which each residue contributes to its biological activity. A key residue is serine at position 14, which is associated with neuroprotective properties. Substitution of this amino acid with glycine results in a more potent variant known as Humanin-G (HNG). Experimental research indicates that HNG exhibits substantially enhanced biological activity compared to native Humanin and is particularly effective in preserving mitochondrial function and cellular integrity under stress conditions. In preclinical and laboratory research settings, Humanin-G has been shown to support cellular survival by limiting mitochondrial dysfunction and reducing pathways associated with programmed cell death. These properties have generated scientific interest in its role within research models of ischemic injury, neurodegenerative processes such as Alzheimer’s disease, and other conditions linked to cellular stress. Based on experimental observations, Humanin-G has been associated with: Protection against mitochondrial dysfunction in stressed cells Reduction of apoptosis-related cellular pathways Support of cellular longevity mechanisms in research models Modulation of insulin sensitivity in experimental systems Neuroprotective effects observed in models of ischemia and neurodegeneration FRESHLY PREPARED SOLUTION 

Myo-Inositol Trispyrophosphate Hexasodium Salt (ITPP) is a compound studied for its ability to influence oxygen delivery dynamics by modulating hemoglobin’s affinity for oxygen. This mechanism has been associated, in experimental settings, with changes in tissue oxygen availability and cellular metabolic processes. In preclinical and laboratory research, ITPP has been explored for its potential impact on metabolic efficiency, oxidative balance, and inflammatory pathways. Its interaction with oxygen-dependent systems has generated scientific interest in areas related to cellular energy metabolism, mitochondrial function, and tissue-level physiology. Additionally, ongoing research has investigated the broader implications of oxygen modulation in contexts such as aging processes, cellular stress response, and complex biological environments including those associated with neurodegenerative and proliferative conditions.

Research and experimental studies indicate that KCF-18 is associated with the following characteristics and biological activities: Interaction with multiple pro-inflammatory cytokine pathways, including TNF-α, IL-1β, and IL-6 Functioning as a cytokine-binding decoy in experimental models Modulation of inflammatory signaling involved in vascular and endothelial processes Influence on immune cell adhesion and transmigration in laboratory settings Potential role in the regulation of immune response signaling Structural design that supports interaction with multiple cytokine-related targets

KPV is a short peptide that has been extensively investigated in experimental models for its role in the modulation of inflammatory responses. Current research has focused primarily on its involvement in studies related to inflammatory bowel disease. Additional studies in wound-healing models suggest that KPV, along with other α-MSH–derived peptides, may influence tissue repair processes, inflammatory regulation, microbial control, and structural outcomes associated with healing. According to experimental and preclinical research, KPV has been studied in relation to:Inflammatory mechanisms associated with acne and cystic acneIntestinal inflammatory signaling in Crohn’s disease research modelsExperimental models of ulcerative colitis and irritable bowel syndromeInflammatory skin conditions such as eczema and psoriasisImmune and inflammatory responses explored in mold- and Lyme-related modelsNeuroinflammatory pathways investigated in multiple sclerosis researchInflammatory conditions affecting skin and ocular tissuesAirway inflammation examined in allergic asthma modelsJoint inflammation studied in arthritis-related research

FGL has been investigated in experimental and preclinical research settings for its role in supporting synapse formation between neurons, a process associated with synaptic plasticity and structural neuronal adaptation. Increased activity-dependent synaptic communication observed in research models suggests that FGL may contribute to information encoding mechanisms underlying learning and memory-related processes. According to experimental studies, FGL has been explored in relation to the following neurobiological contexts: Neuroprotective mechanisms in neuronal stress models Modulation of cognitive performance parameters in experimental systems Neural recovery and adaptation following traumatic brain injury models Protection against experimentally induced neurotoxic stress Memory-related processes in learning paradigms Learning-associated synaptic plasticity mechanisms Neurodegenerative and cognitive decline research models Modulation of neuroinflammatory signaling in central nervous system models Regulation of mood-related behavioral parameters in experimental settings Activity-dependent enhancement of excitatory synaptic transmission    FRESHLY PREPARED SOLUTION 

α-Klotho is a transmembrane and soluble endocrine protein first identified in 1997 and now widely recognized as a key candidate in aging biology. It is expressed predominantly in the kidney and choroid plexus of the brain, and its soluble form circulates in blood, urine, and cerebrospinal fluid. Membrane α-Klotho functions as an essential co-receptor for FGF23, regulating phosphate and vitamin D metabolism. Soluble α-Klotho is studied for its broader endocrine-like effects, including modulation of oxidative stress responses, inflammatory signaling, IGF-1 and mTOR pathways, and Wnt-associated tissue remodeling. Experimental models show that Klotho deficiency is linked to accelerated aging-like phenotypes such as vascular dysfunction, sarcopenia, cognitive decline, cardiac fibrosis, and osteopenia, while elevated Klotho expression is associated with improved cognition, delayed vascular aging, enhanced muscle regeneration, and increased lifespan. Due to its connection with senescence biology, SASP-driven inflammation, kidney decline, and neurodegenerative processes, α-Klotho remains a central molecule in research focused on longevity, metabolic regulation, and systemic resilience.

Setmelanotide is a synthetic peptide and potent melanocortin 4 receptor (MC4R) agonist studied for its ability to restore satiety signaling in rare genetic disorders such as POMC deficiency, PCSK1 deficiency, and leptin-related pathway dysfunction. It works by directly activating MC4R, bypassing upstream genetic defects that impair production of α-MSH and other satiety mediators. Research suggests that setmelanotide has significantly higher potency than endogenous α-MSH and may reduce hyperphagia and support weight loss in genetically defined obesity conditions. Its activity may be influenced by its atypical bitopic binding behavior, interacting with both orthosteric and putative allosteric receptor sites, potentially contributing to improved receptor specificity and a distinct signaling profile compared to earlier MC4R agonists.

GDF-8 is involved in the regulation of myostatin activity, a key biological factor that normally limits muscle growth and regeneration. Experimental and preclinical research indicates that modulation of this pathway influences muscle and tissue dynamics associated with repair and adaptation. According to research-based observations, GDF-8 has been associated with the following effects: Enhancement of muscular regeneration and recovery processes following injury Support of the body’s regenerative capacity at the tissue level Increase in myofiber hypertrophy in experimental models

Tesofensine significantly supports weight loss, body fat reduction, and appetite reduction. It increases an individual's resting energy expenditure by stimulating the fat oxidation process. Below are its main effects: - Reduced body fat / Weight loss - Appetite suppression - Improved libido - Better sleep quality - Improved cognitive function

Vesugen is a short synthetic bioregulatory peptide investigated for its role in vascular and neurovascular regulation. It belongs to a class of organ-specific peptides studied for their potential capacity to modulate gene expression patterns associated with endothelial stability, metabolic regulation, and cellular stress resistance. Experimental models have explored its interaction with genes such as p16 and p21 (cell cycle regulation), as well as pathways linked to SIRT1 activity, which is widely associated with metabolic control, stress adaptation, and longevity-related signaling mechanisms. Within neurovascular research contexts, Vesugen has been examined for its potential role in maintaining microvascular integrity and supporting oxidative balance in neural tissues. Additional research has evaluated Vesugen in the context of endothelial gene expression, nitric oxide signaling balance, and vascular membrane stability. Modulation of endothelin-1 expression and reduction of oxidative vascular markers have been reported in controlled laboratory studies. Overall, Vesugen is characterized in scientific literature as a vascular bioregulatory peptide investigated for its potential epigenetic modulation of gene expression related to endothelial function, neurovascular stability, metabolic balance, and cellular aging pathways.

Testagen is a bioregulatory peptide studied for its potential influence on endocrine balance, particularly in relation to thyroid hormone regulation and testosterone-related signaling. It has been described as a peptide capable of penetrating cellular structures and potentially influencing gene regulatory pathways. Research discussions suggest Testagen may support pituitary activity, increasing thyroid-stimulating hormone (TSH) output and indirectly supporting thyroid hormones T3 and T4, contributing to improved metabolism and energy regulation. It has also been explored for potential relevance in testosterone decline research, age-related vitality reduction, and hormonal imbalance-related conditions. Additional research interest includes its possible influence on hemostasis through thyroid-driven pathways and its potential immune-support relevance by modulating cellular differentiation and immune aging mechanisms.

Zinc Thymulin (FTS – Zinc Complex) is a zinc-coordinated nonapeptide formulation developed for research in scalp and hair follicle biology. The complex integrates peptide-mediated immune signaling modulation with zinc-dependent enzymatic support, reflecting the multidimensional regulation of follicular growth. Within the hair follicle microenvironment, coordinated control of anagen duration, stem cell activation, oxidative balance, and microinflammatory signaling is essential for maintaining hair density and structural integrity. Zinc functions as a critical cofactor in cellular proliferation, keratin synthesis, and antioxidant defense systems, while thymulin has been investigated for its influence on immune-regulatory pathways relevant to follicular stability. Research observations suggest that zinc–thymulin complexes may contribute to maintenance of active growth-phase dynamics, support intermediate hair formation, and promote a balanced follicular microenvironment. Rather than targeting a single pathway, the formulation is studied for its integrated influence on cellular signaling, redox regulation, and micronutrient-dependent processes involved in scalp tissue homeostasis. FRESHLY PREPARED SOLUTION

GDF11 has been shown to improve the outcomes of neurodegenerative and neurovascular diseases, increase the amount of skeletal muscle and boost muscular strength. It also has the power to reverse age-related degenerative alterations, as well as govern organ and skin regeneration following damage. These are all examples of its biological effects, which include reversing senescence.

Orexin-A (Hypocretin-1) is a neuropeptide derived from the lateral hypothalamus and plays a central role in sleep–wake regulation, arousal stability, and autonomic balance. It interacts with orexin receptors OXR1 and OXR2 and modulates key neurotransmitter systems including dopamine, norepinephrine, serotonin, and histamine. Experimental research has examined Orexin-A in models of narcolepsy, sleep–wake dysregulation, neuroinflammation, thermoregulation, and autonomic control. Due to its ability to cross the blood–brain barrier, Orexin-A remains a molecule of interest in central nervous system signaling research. Orexin-B (Hypocretin-2) is a hypothalamic neuropeptide primarily interacting with the orexin receptor OXR2, contributing to sleep–wake homeostasis and arousal regulation. Unlike Orexin-A, Orexin-B exhibits receptor selectivity toward OXR2, making it a valuable tool for receptor-specific signaling studies. Preclinical research has investigated Orexin-B in the context of narcolepsy models, vigilance state regulation, autonomic modulation, and neuroendocrine signaling. Its receptor selectivity provides insight into differential orexin pathway activation in sleep and arousal research. FRESHLY PREPARED SOLUTION

Follistatin-344 is a synthetic analogue of the naturally occurring follistatin protein. In preclinical and experimental research, it has been investigated for its interactions with signaling pathways involving myostatin, activins, and follicle-stimulating hormone (FSH). Findings from in vitro and animal studies suggest that modulation of these pathways may be associated with changes in cellular differentiation processes, tissue remodeling dynamics, and selected regulatory signaling mechanisms. These observations position Follistatin-344 as a molecule of interest in research contexts focused on tissue biology, regenerative signaling, and growth-regulatory pathways.

MIF-1 (Melanocyte-Inhibiting Factor 1) has been investigated for its role in central nervous system signaling and neuronal regulation. Scientific studies have examined MIF-1 in relation to multiple biological processes associated with brain function, neurochemical balance, and cellular resilience. Research has primarily focused on MIF-1 in the context of the following areas: Neurotransmitter Modulation: Associated with the regulation of dopamine and serotonin signaling pathways involved in motor function and mood-related processes. Neuroplasticity: Linked to mechanisms that support synaptic plasticity relevant to learning and memory in experimental research. Neuroprotective Activity: Studied for its involvement in cellular pathways that help protect neurons from oxidative and inflammatory stress. Neuroregenerative Processes: Investigated for its role in mechanisms related to neuronal repair and cellular renewal in research models of neural injury. Mood-Related Signaling: Explored for its influence on neurochemical pathways associated with emotional regulation and stress responses. Cognitive Function: Associated in experimental settings with processes relevant to memory, attention, and higher-order cognitive performance. Neurodegenerative Research: Examined in studies focused on biological pathways involved in neurodegenerative conditions and age-related neural changes.

HCG is a glycoprotein hormone studied in research contexts for its role in gonadotropin-related signaling pathways and endocrine regulatory mechanisms. It is associated with receptor-mediated processes involved in hormonal communication and system-wide endocrine coordination. Due to its well-characterized structure and role in endocrine signaling, HCG remains a key compound in experimental models investigating regulatory pathways of the hypothalamic–pituitary–gonadal axis.

Adenosine monophosphate (AMP) has a well-known experimental analog in the molecule AICAR. In preclinical research models, AICAR has been extensively used to investigate AMPK-mediated cellular energy regulation, metabolic stress responses, and redox balance. In in vitro systems and animal studies, AICAR has been evaluated in experimental contexts related to cardiac ischemia models, where AMPK activation has been associated with modulation of cellular survival pathways under ischemic stress. Due to its role in regulating oxidative stress and energy metabolism, AICAR has also been studied in experimental ageing-related models, as well as in preclinical models of metabolic and inflammatory dysregulation, including those used to investigate mechanisms relevant to insulin signaling, immune activation, and chronic inflammation. These findings are limited to controlled laboratory and animal research settings and are used to explore underlying biological mechanisms rather than clinical applications.

Livagen is a short bioregulatory peptide that has been investigated in experimental research for its influence on DNA organization and gene expression. It is primarily recognized for its association with chromatin decondensation, a process that increases DNA accessibility and has been linked to cellular profiles typically observed in younger cells. Scientific research has focused predominantly on immune system lymphocytes, where Livagen has been shown to modulate gene activity and cellular function. Through these mechanisms, Livagen has been studied for its involvement in biological processes related to immune regulation and signaling pathways associated with cardiovascular, gastrointestinal, neurological, and immune system function. Experimental findings have also explored Livagen’s role in nociception and pain-related signaling. Ongoing research continues to examine Livagen’s broader relevance in studies of aging, cellular senescence, and long-term biological regulation. FRESHLY PREPARED SOLUTION

Cortagen has been investigated in preclinical and exploratory research settings for its potential involvement in brain reparative processes, cerebroprotective responses, and nootropic-like activity, within experimental models of cerebral stress and degeneration. Research literature has explored Cortagen in relation to the following neurobiological contexts: Cerebral lesion and injury models Neurodegenerative and dementing process models, including protein-aggregation and vascular-associated degeneration Extrapyramidal and movement-disorder research models Spinal and cerebellar system dysfunction models Central nervous system involvement in immune-mediated and inflammatory conditions Motor impairment and hemiplegia-related models Paralytic and neuromuscular dysfunction models Cerebral involvement in bacterial meningeal inflammation models Hemorrhagic cerebral stress models Transient and persistent cerebral ischemia models  FRESHLY PREPARED SOLUTION 

Taltirelin is a synthetic TRH analogue studied primarily for its effects in spinocerebellar degeneration and related motor coordination disorders. Acting as a biased superagonist at TRH-R1, it influences central neurotransmission and has been investigated for neuroprotective, anti-ataxic, and pro-cognitive effects. Research suggests taltirelin may modulate multiple neurotransmitter systems, including acetylcholine, dopamine, serotonin, and noradrenaline, contributing to interest in its potential relevance for memory impairment, depressive-like conditions, arousal regulation, and fatigue-related disorders. Additional studies have explored its antinociceptive properties and possible effects on neurite outgrowth and spinal cord-related neural recovery, making it a notable peptide in experimental research involving neurodegeneration, cognition, and neurological resilience. FRESHLY PREPARED SOLUTION

1 box/5 Pieces

GHRP-6 is a synthetic hexapeptide classified as a growth hormone secretagogue and a selective agonist of the ghrelin receptor (GHS-R1a). It is studied in research contexts for its interaction with receptor-mediated signaling pathways involved in endocrine regulation and neuroendocrine communication processes. Due to its well-characterized receptor activity, GHRP-6 remains a compound of interest in experimental models investigating ghrelin-related signaling and growth hormone regulatory pathways.

Adenosine monophosphate (AMP) has a well-known experimental analog in the molecule AICAR. In preclinical research models, AICAR has been extensively used to investigate AMPK-mediated cellular energy regulation, metabolic stress responses, and redox balance. In in vitro systems and animal studies, AICAR has been evaluated in experimental contexts related to cardiac ischemia models, where AMPK activation has been associated with modulation of cellular survival pathways under ischemic stress. Due to its role in regulating oxidative stress and energy metabolism, AICAR has also been studied in experimental ageing-related models, as well as in preclinical models of metabolic and inflammatory dysregulation, including those used to investigate mechanisms relevant to insulin signaling, immune activation, and chronic inflammation. These findings are limited to controlled laboratory and animal research settings and are used to explore underlying biological mechanisms rather than clinical applications.   FRESHLY PREPARED SOLUTION 

Ovagen is a bioregulatory peptide that has been studied for its role in supporting gastrointestinal mucosal integrity and maintaining normal liver tissue structure. Research suggests it may help protect the gastrointestinal mucosal layer from stressors such as antibiotics, toxins, and anti-inflammatory agents, while also being associated with reduced fibrotic processes in liver tissue. Ongoing experimental studies are further evaluating Ovagen’s interaction with mechanisms involved in HIV viral replication.

Cardiogen is a short synthetic peptide used in preclinical research models to study fibroblast-associated signaling and tissue remodeling mechanisms. In in vitro systems and animal studies, it has been investigated for its role in regulating cellular processes involved in extracellular matrix organization and scar-related responses under experimental conditions. FRESHLY PREPARED SOLUTION 

Chonluten has been explored in relation to the regulation of pulmonary mucosa, gene networks involved in inflammatory and antioxidant processes, and tissue adaptation mechanisms across a broad range of acute and chronic respiratory and systemic stress conditions, of both infectious and non-infectious origin, including age-associated functional decline. Experimental findings indicate a predominant activity within pulmonary tissue, with secondary involvement observed in the gastrointestinal tract. Specifically, Chonluten has been studied in preclinical research contexts involving: post-infectious pulmonary recovery states chronic cardiopulmonary functional impairment persistent respiratory dysfunction recovery phases following prolonged mechanical ventilation long-term pulmonary adaptation after remission of granulomatous conditions acute respiratory distress and hypoxia-associated states high physiological load and exercise-related respiratory stress maintenance of respiratory function in ageing biological systems inflammation-driven pulmonary mucosal dysregulation inflammatory states and alterations of the gastrointestinal mucosa FRESHLY PREPARED SOLUTION 

B7-33 has been investigated in preclinical research models related to: Fibrotic tissue remodeling models Vascular protection and endothelial signaling models Cardiac injury and post-ischemic remodeling models Pulmonary inflammation and fibrosis-related models  FRESHLY PREPARED SOLUTION 

Orexin-A is a neuropeptide that has been extensively studied for its role in the regulation of wakefulness and arousal. Research has also explored its involvement in pathways related to appetite regulation, locomotor activity, and autonomic nervous system signaling, including modulation of sympathetic tone. These findings highlight the importance of Orexin-A in maintaining physiological balance across sleep–wake cycles and energy-related processes.

ATN-161 is a synthetic pentapeptide used in preclinical research models to study integrin–extracellular matrix interactions, particularly those involving fibronectin binding. In in vitro systems and animal studies, modulation of these interactions has been employed to investigate cell adhesion, migration, angiogenesis-related signaling, and tissue remodeling mechanisms under experimental conditions.

RTD-1 is a macrocyclic θ-defensin peptide expressed in Old World monkeys and studied for its broad-spectrum antibacterial, antifungal, and antiviral activity. Research indicates it may function by interacting with microbial membranes while also exerting significant immunomodulatory effects. Notably, experimental studies in a rodent model of rheumatoid arthritis showed that RTD-1 rapidly suppressed and reversed autoimmune joint disease, improving mobility and preserving joint structure. Mechanistically, RTD-1 reduced joint IL-1β levels, inhibited IL-6 production, suppressed fibroblast-like synoviocyte invasiveness, and inhibited destructive proteases such as ADAM17/ADAM10, metalloproteases, and cathepsin K. These properties have positioned RTD-1 as a promising research peptide of interest in antimicrobial defense and inflammation-related disease models.

GcMAF Frag (Gc protein–derived macrophage activating factor fragment) is a peptide fragment derived from vitamin D–binding protein (DBP) and studied for its interaction with macrophages, key cells of the innate immune system involved in immune surveillance and phagocytic processes. In experimental and preclinical research settings, GcMAF Frag has been investigated for its ability to influence macrophage-associated signaling pathways and immune-related functional markers. Within controlled laboratory models, exposure to GcMAF-related fragments has been associated with modulation of macrophage activity, including phagocytosis-related assays and cytokine-associated readouts. For this reason, the peptide is primarily used as a research tool in studies focused on immune regulation, inflammatory signaling, and host defense mechanisms. Chemical modifications such as N-terminal acetylation and C-terminal amidation have been evaluated in peptide research for their impact on structural stability and resistance to enzymatic degradation. In experimental systems, these features may contribute to enhanced molecular stability, prolonged functional persistence, and optimized receptor interaction profiles under in vitro conditions.

1 box/50 Pieces

PHDP5 + TAT (44–57) is a synthetic peptide construct designed for advanced Alzheimer’s disease research, combining the PHDP5 sequence with a TAT cell-penetrating domain to enhance brain delivery and intracellular uptake. In preclinical Alzheimer’s disease models, PHDP5 has been reported to rescue learning and memory loss in Alzheimer’s disease, restoring cognitive performance to levels comparable to healthy controls. The mechanism is associated with inhibition of the pathological dynamin–microtubule interaction induced by tau, leading to recovery of synaptic vesicle endocytosis and neuronal communication. The addition of TAT (44–57) enables efficient penetration into brain tissue, including the hippocampus, following intranasal administration. While the peptide demonstrates strong effects on synaptic function and cognitive deficits in experimental Alzheimer’s models, its activity is primarily linked to tau-related dysfunction rather than direct amyloid plaque removal.

SS-31 (Elamipretide) is a mitochondria-targeting peptide studied for its ability to bind cardiolipin in the inner mitochondrial membrane, stabilize mitochondrial structure, and support cellular energy production. Research suggests that SS-31 may reduce mitochondrial oxidative stress by limiting reactive oxygen species accumulation, improving mitochondrial bioenergetics, and supporting membrane integrity. It has also been investigated for its ability to modulate the mitochondrial permeability transition pore (mPTP), potentially reducing apoptosis-related signaling under stress. Due to these mechanisms, SS-31 has attracted attention in research involving neurodegenerative diseases, cardiovascular disorders, age-related mitochondrial decline, and retinal diseases such as diabetic retinopathy and age-related macular degeneration. FRESHLY PREPARED SOLUTION 

Colivelin is a humanin-family peptide that has been extensively investigated in preclinical research models for its involvement in neuronal stress-response pathways. Experimental studies conducted in vitro and in vivo indicate that Colivelin may influence mechanisms associated with amyloid-related aggregation processes, neuronal apoptosis, and synaptic plasticity regulation under neurodegenerative conditions.   

cAC-253 is a disulfide-cyclized research peptide used in preclinical experimental models to investigate amylin receptor–mediated signaling under conditions of amyloid-associated cellular stress. In in vitro systems and animal studies, cAC-253 has been explored for its effects on synaptic function, learning- and memory-related signaling pathways, amyloid-associated biochemical markers, and neuroinflammatory responses, providing a tool for mechanistic research into receptor-specific pathways involved in synaptic integrity.

Thyroidget (Asp–Trp) is a short bioregulatory peptide studied for its potential antioxidant and anti-inflammatory properties. Research suggests it may support cellular protection against oxidative stress and modulate inflammatory signaling pathways, making it relevant in studies involving chronic inflammatory disorders, cardiovascular risk models, and systemic aging processes. Due to the thyroid gland’s high metabolic activity and vulnerability to oxidative injury, Thyroidget has attracted interest as a peptide potentially supporting thyroid homeostasis and endocrine resilience, including research contexts related to autoimmune thyroid conditions. Emerging investigations also suggest possible neuroprotective relevance in models of neurodegenerative disease. Thyroidget is considered moderately water-soluble, with solubility influenced by pH, concentration, and ionic conditions.